$420
Antitrust Class Action, Securities Fraud
Case results reflect publicly available information reported by the listed law firms. They are not results obtained by ThatCarHitMe.com. Every case is unique and must be evaluated on its own facts. Prior results do not guarantee a similar outcome. The results shown are not necessarily representative of all results obtained by these firms. No representation is made that the quality of legal services to be performed is greater than the quality of legal services performed by other lawyers.
Case Details
Preliminary approval for a $420 million all-cash settlement in a class action against Teva for misrepresentations related to its generics drug business and alleged price-fixing practices. Case name: In Re Teva Securities Litigation, No. 3:17-cv-00558 (D. Conn.). Schneider Wallace represents direct action plaintiff health plans in a related MDL.
Additional Notes
Case name: In Re Teva Securities Litigation, No. 3:17-cv-00558 (D. Conn.). Schneider Wallace represents direct action plaintiff health plans in a related MDL.